Melatonin Viatris

Melatonin, the active ingredient in Melatonin Viatris, is a melatonin receptor agonist presented as an oral tablet for oral use. It is employed to help regulate sleep patterns and is indicated for adults experiencing insomnia or circadian rhythm disturbances.

GNH USA supplies Melatonin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides batch‑tested product for global distribution. Our logistics network ensures timely delivery and regulatory compliance across multiple regions.

Melatonin is used to address sleep‑related disorders by influencing the body's circadian signaling pathways. - Insomnia: helps reduce sleep onset latency and improve total sleep time in adults. - Delayed sleep‑phase disorder: advances sleep timing to align with desired bedtime. - Non‑24‑hour sleep‑wake rhythm disorder: stabilizes the sleep‑wake cycle in individuals with irregular rhythms. - Jet lag: assists in re‑synchronizing the internal clock after rapid time‑zone travel.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate headache reported. - Drowsiness: excessive daytime sleepiness. - Dizziness: transient light‑headedness. - Nausea: mild gastrointestinal upset. - Vivid dreams: unusual or intense dreams.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Hormonal effects: menstrual irregularities in women. - Cardiovascular: palpitations or rapid heart rate. - Severe sleep disturbances: paradoxical insomnia.

When considering melatonin therapy, several safety considerations should be reviewed. - Age limitation: use in children should be under medical supervision. - Pregnancy: safety not established; discuss risks with a healthcare provider. - Breastfeeding: potential transfer to milk; evaluate benefit‑risk ratio. - Concomitant CNS depressants: may enhance sedative effects. - Underlying disorders: assess for depression or seizure disorders before use. - Store at ambient temperature: keep in original container, protect from moisture and light.

Melatonin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: potential reduction of drug effectiveness.

Moderate Interactions (Monitor Closely): - Sedatives (benzodiazepines, Z‑drugs): additive sleep‑inducing effect. - Antidepressants (SSRIs, MAOIs): possible serotonin syndrome risk. - Oral contraceptives: may reduce melatonin clearance, increasing levels. - Caffeine: may diminish melatonin’s sleep‑promoting action.